Published on 05/12/2025
Digital Tools and Software to Enable Combined & Companion QMS for Medical Devices & Combination Products in Modern eQMS Platforms
Introduction to Combined & Companion QMS
In the regulated environments of the pharmaceutical, biotech, and medical device industries, the implementation of a robust Quality Management System (QMS) is crucial for ensuring compliance with standards such as ISO 13485, FDA regulations, and Good Manufacturing Practices (GMP). This article serves as a step-by-step tutorial for quality managers, regulatory affairs, and compliance professionals on how to effectively utilize digital tools and software to
Step 1: Understanding the Objectives of a Combined & Companion QMS
The first phase in developing a combined and companion QMS is to clearly define its objectives. A combined QMS integrates processes for both medical devices and pharmaceuticals, while a companion QMS focuses on the relationship between these products, particularly in combination therapies.
Objectives:
- Ensure compliance with regulatory requirements from the FDA, EMA, and MHRA.
- Facilitate seamless integration of quality processes across product lines.
- Enhance risk management and mitigation strategies.
- Improve product lifecycle management.
Documentation: Key documents include the Quality Manual, Standard Operating Procedures (SOPs), and risk management plans.
Roles: Quality managers should lead the initiative, while cross-functional teams including regulatory affairs, R&D, and manufacturing must collaborate.
Inspection Expectations: Regulatory bodies will expect documented evidence of compliance, risk assessments, and integration of quality processes during inspections.
Step 2: Selecting the Right eQMS Platform
Choosing an appropriate electronic Quality Management System (eQMS) platform is vital for the successful implementation of a combined and companion QMS. The platform should support the specific needs of both medical devices and combination products.
Objectives:
- Ensure the eQMS is compliant with FDA 21 CFR Part 820 and ISO 13485.
- Facilitate data integrity and security.
- Provide user-friendly interfaces for all stakeholders.
Documentation: Vendor evaluations, system requirements specifications, and validation protocols must be prepared.
Roles: IT specialists, quality managers, and end-users should be involved in the selection process.
Inspection Expectations: Inspectors will review the eQMS for compliance with data integrity standards and its ability to generate necessary documentation.
Step 3: Developing Integrated Quality Processes
Once the eQMS platform is selected, the next step is to develop integrated quality processes that encompass both medical devices and combination products. This involves harmonizing quality standards and practices across different product lines.
Objectives:
- Streamline quality processes to reduce redundancy.
- Enhance communication and collaboration among departments.
- Ensure consistent quality across all products.
Documentation: Updated SOPs, process flowcharts, and training materials should be created.
Roles: Quality assurance teams, regulatory affairs, and production personnel must collaborate to ensure processes meet regulatory expectations.
Inspection Expectations: Inspectors will assess the integration of processes and their effectiveness in maintaining compliance.
Step 4: Training and Change Management
Training is a critical component of implementing a combined and companion QMS. All employees must understand the new processes and their roles within the system.
Objectives:
- Ensure all personnel are adequately trained on the new eQMS and quality processes.
- Facilitate a smooth transition to the new system.
- Reduce resistance to change by involving staff in the process.
Documentation: Training records, competency assessments, and feedback forms should be maintained.
Roles: Training coordinators and department heads should oversee training efforts.
Inspection Expectations: Inspectors will review training records and assess the effectiveness of training programs during audits.
Step 5: Continuous Monitoring and Improvement
After the implementation of the combined and companion QMS, continuous monitoring and improvement are essential to maintain compliance and enhance quality.
Objectives:
- Identify areas for improvement within the QMS.
- Ensure ongoing compliance with regulatory requirements.
- Foster a culture of quality within the organization.
Documentation: Quality metrics, audit reports, and corrective action plans should be documented and reviewed regularly.
Roles: Quality managers and internal auditors should lead continuous improvement initiatives.
Inspection Expectations: Inspectors will look for evidence of ongoing monitoring, audit results, and actions taken to address non-conformities.
Conclusion
Implementing a combined and companion QMS for medical devices and combination products is a complex but necessary process in today’s regulated environments. By following these steps—defining objectives, selecting the right eQMS platform, developing integrated quality processes, ensuring effective training, and committing to continuous improvement—organizations can enhance their compliance posture and product quality. As regulatory expectations evolve, staying ahead with a robust QMS will not only ensure compliance but also foster innovation and improve patient safety.
For further guidance on QMS implementation, consider reviewing resources from the FDA, EMA, and ISO.